Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients

Lancet Infect Dis. 2023 Aug;23(8):e266-e267. doi: 10.1016/S1473-3099(23)00357-2. Epub 2023 Jun 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Humans
  • Immunocompromised Host
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Antibodies, Viral
  • Antibodies, Neutralizing